Approximately one in ten residents in Kalmar County lives with asthma. However, a significant majority of patients across Sweden do not receive adequate clinical care or proper follow-up management, according to recent findings.
Medical experts emphasize that while most individuals diagnosed with asthma can achieve symptom-free control with appropriate medical treatment, unmanaged disease drives preventable suffering. According to the Astma- och Allergiförbundet, seven out of ten individuals with asthma fail to receive the correct level of clinical care. This gap in management frequently results in acute flare-ups, recurrent emergency room visits, diminished quality of life, and permanent structural lung damage over time.
The data emerging from Swedish public health evaluations underscores a systemic disconnect between existing pharmaceutical solutions and everyday clinical routines. When routine assessments lapse, patients often normalize chronic coughing, persistent breathlessness, and reduced daily activity.
Systemic Gaps in Swedish Asthma Care
Recent evaluations published by the National Board of Health and Welfare (Socialstyrelsen) reveal that systematic assessments of symptom control are rarely conducted on a routine basis. According to Socialstyrelsen data, regular evaluations of symptom management occurred for only 49 percent of adult asthma patients and 57 percent of children up to 18 years of age.
Healthcare professionals point to several primary drivers behind these substandard care metrics. Approximately half of all registered patients report never being called in for an annual clinical review. Instead of scheduled reassessments, prior prescriptions are frequently renewed automatically without verifying current lung function or therapeutic efficacy. Furthermore, many patients receive insufficient practical instruction on how to correctly operate inhalers, leading to improper medication administration.
The societal cost of unmanaged airway disease is substantial. Data indicates that a person with very poorly controlled asthma costs 107 000 kronor per year – six times more than a person with well-controlled asthma, who costs 17 000 kronor per year.
Launching Astmakontroll Sverige
To bridge the gap between clinical guidelines and everyday practice, stakeholder groups have initiated a coordinated national effort. Mikaela Odemyr, förbundsordförande Astma- och Allergiförbundet, announced the rollout of Astmakontroll Sverige, a collaborative initiative uniting patient organizations, regional healthcare providers, and academic researchers.
“Det som saknas är inte lösningar utan att de lösningar som redan finns faktiskt används,” Odemyr stated. “För varje utebliven kontroll och varje slentrianmässigt förnyat recept riskerar vi att människor fastnar i en onödig sjukdomssituation. Det är oacceptabelt.”
The newly formed national coalition aims to ensure that more patients receive structured clinical follow-ups, comprehensive education regarding their chronic condition, and optimized pharmaceutical regimens. Organizers stress that living with restricted lung capacity should not be accepted as a baseline norm for hundreds of thousands of affected individuals throughout Sweden.
Next Steps for Patients and Healthcare Providers
Patients seeking guidance on symptom control, annual reviews, or correct inhalation techniques can access advisory resources directly through Astma- och Allergiförbundet.
Related reading